[Pharmaceutical intervention to reduce the iatrogenic risk associated with the triple whammy combination].

Abstract

OBJECTIVE To analyze the effect of an intervention to reduce the iatrogenic risk associated with concomitant treatment with angiotensin converting enzyme inhibitors (ACEi) and/or angiotensin-II receptor blockers (ARB) with diuretics and nonsteroidal anti-inflamatory drugs (NSAID), combination known as triple whammy (TW). DESIGN Uncontrolled before-after… (More)
DOI: 10.1016/j.aprim.2016.05.007

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.